Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Capital Expenditures (2016 - 2023)

Milestone Scientific's Capital Expenditures history spans 14 years, with the latest figure at $1192.0 for Q1 2023.

  • For Q1 2023, Capital Expenditures changed N/A year-over-year to $1192.0; the TTM value through Mar 2023 reached $1595.0, down 82.8%, while the annual FY2022 figure was $8527.0, 43.86% down from the prior year.
  • Capital Expenditures for Q1 2023 was $1192.0 at Milestone Scientific, down from $4700.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $8361.0 in Q2 2020 and bottomed at -$4297.0 in Q4 2021.
  • The 5-year median for Capital Expenditures is $5939.0 (2020), against an average of $4766.8.
  • The largest annual shift saw Capital Expenditures skyrocketed 492.4% in 2019 before it decreased 17.12% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at $1812.0 in 2019, then soared by 227.76% to $5939.0 in 2020, then plummeted by 172.35% to -$4297.0 in 2021, then soared by 209.38% to $4700.0 in 2022, then tumbled by 74.64% to $1192.0 in 2023.
  • Per Business Quant, the three most recent readings for MLSS's Capital Expenditures are $1192.0 (Q1 2023), $4700.0 (Q4 2022), and -$4297.0 (Q4 2021).